Jetstream Capital LLC Tg Therapeutics, Inc. Transaction History

Jetstream Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $4.36 Million - $8.09 Million	-200,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $2.6 Million - $3.92 Million	80,000 Added 66.67%	200,000 $7.76 Million
Q1 2021 May 17, 2021	BUY	$41.61 - $54.3 $3.66 Million - $4.78 Million	88,000 Added 275.0%	120,000 $5.78 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $808,640 - $1.76 Million	32,000 New	32,000 $1.67 Million

269

87.7M

2.72M

1.74M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $2.76B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Jetstream Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Jetstream Capital LLC with notifications on news.